WuXi receives bid to take it private

By Zachary Brennan

- Last updated on GMT

WuXi receives bid to take it private

Related tags Manufacturing Finance

China-based contract research and manufacturing company WuXi PharmaTech has received a proposal to be taken private by a consortium led by its CEO and Ally Bridge Group Capital Partners.

Under the proposal by CEO Ge Li and Ally, the group would  purchase all remaining shares for $46, which would provide a 16.5% premium to WuXi's closing price on Wednesday. This morning the shares rose to $46.

The purchase is intended to be financed with a combination of debt and equity capital.  The proposal letter also states that Li and Ally have agreed to work together exclusively in pursuing the transaction.

Related topics Clinical Development

Related news

Show more

Follow us

Webinars